In adults with active cancer and suspected PE, the YEARS algorithm was noninferior to CTPA alone for ruling out VTE at 3 mo.

The YEARS algorithm effectively rules out venous thromboembolism (VTE) in adults with active cancer, showing noninferiority to computed tomography pulmonary angiography (CTPA) at 3 months.

• Why it matters: Accurate and safe VTE diagnosis in cancer patients is critical to avoid unnecessary imaging and treatment, yet current methods lack efficiency or carry risks.
• What they did: The study compared the YEARS algorithm with CTPA in adults with active cancer and suspected pulmonary embolism, assessing outcomes over a 3-month period.
• The result: Findings demonstrate that the YEARS algorithm is a reliable alternative to CTPA, enabling safer, less invasive VTE management in this high-risk population.